+36.1%
MRNA vs VEU
+73.8%
-37.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VEU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.0% | +4.3% | +3.6% |
| 7D | -1.1% | -1.4% | +0.3% | +1.4% |
| 30D | +126.1% | -0.4% | +126.5% | +129.4% |
| 3M | +190.0% | +2.5% | +187.5% | +180.4% |
| 6M | +157.2% | +11.1% | +146.1% | +117.6% |
| YTD | +388.2% | +16.5% | +371.7% | +280.8% |
| 1Y | +467.0% | +22.9% | +444.1% | +305.1% |
| 3Y | +36.1% | +73.4% | -37.3% | -42.6% |
| All | +36.1% | +73.8% | -37.7% | -42.6% |
Cumulative growth
Daily Returns
Daily percentage return beside VEU.
Daily Out/Under-Performance
Portfolio return minus VEU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling